Monthly Archives: June 2026

Community Pharmacy England has negotiated a record 254 price concessions for June, making this the fourth consecutive month of record highs, with some further requests still being negotiated. Community Pharmacy England continues to raise the impact of low Drug Tariff prices and dispensing at a loss by pharmacy owners, and the need for margin reforms, [...]

The post Concession numbers still going up, warns CPE appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Flucloxacillin Capsules BP 500mg (Flamingo Pharma UK Ltd) Drug Alert Number: EL(26)A/32 Date issued: 30 June 2026 Flamingo Pharma UK Ltd have informed the MHRA that certain packs of Flucloxacillin Capsules BP 500mg contain the incorrect PIL. The affected packs contain the PIL for Amoxicillin 500mg Capsules instead of the PIL [...]

The post MHRA Class 3 Medicines Recall: Flucloxacillin Capsules BP 500mg (Flamingo Pharma UK Ltd) appeared first on Community Pharmacy England.

Update 07/07/2026: This Class 4 Medicines Defect Notification has been updated since its initial publication on 30 June 2026 to correct the expiry date for Gabapentin Relonchem 50 mg/ml Oral Solution, batch 21F1. Relonchem Limited has advised that the expiry date previously provided for batch 21F1 was incorrect. The correct expiry date is 01/04/2027. All [...]

The post MHRA Class 4 Medicines Defect Notification: Gabapentin Relonchem 50mg/ml Oral Solution (Relonchem Limited) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (30/06/2026) confirmed the following list of price concessions for June 2026: Please note: Community Pharmacy England has submitted price concession applications for other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department.  Drug Pack [...]

The post June 2026 Price Concessions 4th Update appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited) Drug alert number: EL(26)A/30 Date issued: 29 June 2026 Brancaster Pharma Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification were [...]

The post MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited) appeared first on Community Pharmacy England.